title: HeartWare third-generation implantable continuous flow pump as biventricular support: mid-term follow-up.
abstract: A long-term mechanical biventricular support by HeartWare HVAS third-generation continuous flow pump (HeartWare, Inc, Miramar, FL, USA) was implanted in a Korean patient with a small chest size for treatment of a refractory end-stage heart failure due to an idiopathic dilative cardiomyopathy. We report our experience with a single patient and the early mid-term follow-up results with such a mechanical ventricular support.
authors.affiliation: Department of Cardiac Surgery and Transplantation, San Camillo Hospital, P.za C. Forlanini n. 1, 00151 Rome, Italy. antonioloforte@yahoo.it
authors.forename: Antonio
authors.initials: A
authors.lastname: Loforte
authors.forename: Paola Lilla Della
authors.initials: PL
authors.lastname: Monica
authors.forename: Andrea
authors.initials: A
authors.lastname: Montalto
authors.forename: Francesco
authors.initials: F
authors.lastname: Musumeci
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000150:complications*; D006333:Heart Failure / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D006353:Heart-Assist Devices / Q000009:adverse effects; D006470:Hemorrhage / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007558:Italy; D008297:Male; D011474:Prosthesis Design; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D016276:Ventricular Function
chemical_list: D000925:Anticoagulants